Evidence map›Paper›PMID 28193005›Full record

ArticleAnalytical chemistry2017

Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis.

Jing Li, Hui Wei, Stanley R Krystek, Derek Bond, Ty M Brender, Daniel Cohen, Jena Feiner, Nels Hamacher, Johanna Harshman, Richard Y-C Huang and 12 more

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. State-of-the-Art and Future Directions in Structural Proteomics.Molecular & cellular proteomics : MCP · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Investigation of D76N βJournal of the American Society for Mass Spectrometry · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Jing LiDepartment of Chemistry, Washington University in St. Louis , St. Louis, Missouri 63130-4889, United States.
Hui WeiBiologics Development, Bristol-Myers Squibb , 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, United States.
Stanley R KrystekMolecular Structure & Design, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Derek BondProcess Development, Bristol-Myers Squibb , 1201 Eastlake Ave E., Seattle Washington 98102, United States.
Ty M BrenderDiscovery Biology, Bristol-Myers Squibb , 1201 Eastlake Ave E., Seattle Washington 98102, United States.
Daniel CohenProtein Science, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Jena FeinerApplied Genomics, Bristol-Myers Squibb , 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, United States.
Nels HamacherMolecular Structure & Design, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Johanna HarshmanMolecular Structure & Design, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Richard Y-C HuangBioanalytical and Discovery Analytical Sciences, Research and Development, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Susan H JulienProtein Engineering, Bristol-Myers Squibb , 1201 Eastlake Ave E., Seattle Washington 98102, United States.
Zheng LinProtein Science, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Kristina MooreProtein Science, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Luciano MuellerBioanalytical and Discovery Analytical Sciences, Research and Development, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Claire NoriegaProtein Engineering, Bristol-Myers Squibb , 1201 Eastlake Ave E., Seattle Washington 98102, United States.
Preeti SejwalBioanalytical and Discovery Analytical Sciences, Research and Development, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Paul SheppardProtein Engineering, Bristol-Myers Squibb , 1201 Eastlake Ave E., Seattle Washington 98102, United States.
Brenda StevensProtein Engineering, Bristol-Myers Squibb , 1201 Eastlake Ave E., Seattle Washington 98102, United States.
Guodong ChenBioanalytical and Discovery Analytical Sciences, Research and Development, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Adrienne A TymiakBioanalytical and Discovery Analytical Sciences, Research and Development, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.
Michael L GrossDepartment of Chemistry, Washington University in St. Louis , St. Louis, Missouri 63130-4889, United States.ORCID 0000-0003-1159-4636
Lumelle A SchneeweisProtein Science, Bristol-Myers Squibb , Rt. 206 & Province Line Rd., Princeton, New Jersey 08543, United States.ORCID 0000-0003-3226-0774
Bristol-Myers Squibb (United States) · USWashington University in St. Louis · US

Funding

TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
A MASS SPECTROMETER FOR PROTEIN FOOTPRINTINGS10OD016298 · OD · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 2014 to 2014
$450k
NIGMS NIH HHS P41 GM103422NIH HHS S10 OD016298
6 · The paper itself

Abstract

Epitope mapping the specific residues of an antibody/antigen interaction can be used to support mechanistic interpretation, antibody optimization, and epitope novelty assessment. Thus, there is a strong need for mapping methods, particularly integrative ones. Here, we report the identification of an energetic epitope by determining the interfacial hot-spot that dominates the binding affinity for an anti-interleukin-23 (anti-IL-23) antibody by using the complementary approaches of hydrogen/deuterium exchange mass spectrometry (HDX-MS), fast photochemical oxidation of proteins (FPOP), alanine shave mutagenesis, and binding analytics. Five peptide regions on IL-23 with reduced backbone amide solvent accessibility upon antibody binding were identified by HDX-MS, and five different peptides over the same three regions were identified by FPOP. In addition, FPOP analysis at the residue level reveals potentially key interacting residues. Mutants with 3-5 residues changed to alanine have no measurable differences from wild-type IL-23 except for binding of and signaling blockade by the 7B7 anti-IL-23 antibody. The M5 IL-23 mutant differs from wild-type by five alanine substitutions and represents the dominant energetic epitope of 7B7. M5 shows a dramatic decrease in binding to BMS-986010 (which contains the 7B7 Fab, where Fab is fragment antigen-binding region of an antibody), yet it maintains functional activity, binding to p40 and p19 specific reagents, and maintains biophysical properties similar to wild-type IL-23 (monomeric state, thermal stability, and secondary structural features).

Indexed as

AlanineAntibodies, MonoclonalAntigen-Antibody ReactionsCloning, MolecularDeuterium Exchange MeasurementEpitope MappingEpitopesImmunoglobulin Fab FragmentsInterleukin-23Mass SpectrometryModels, MolecularMutagenesisOxidation-ReductionProtein BindingAlanineAntibodies, MonoclonalEpitopesImmunoglobulin Fab FragmentsInterleukin-23

Identifiers

PMID28193005
PMCPMC5347259
OpenAlexW2568673301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.